CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Ikarian Capital, LLC's Holding History (CIK: 0001778253)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 130,902 Value ($000) $5,452 Avg Close $31.97 Range $25.83 - $47.41

Q2 2025

Shares 433,431 Value ($000) $12,465 Avg Close $30.88 Range $24.10 - $34.68

Q1 2025

Shares 523,431 Value ($000) $17,556 Avg Close $37.35 Range $31.65 - $53.55

Q4 2024

Shares 516,431 Value ($000) $26,405 Avg Close $55.95 Range $49.48 - $62.53

Q3 2024

Shares 426,913 Value ($000) $21,815 Avg Close $51.57 Range $43.71 - $55.78

Q2 2024

Shares 588,818 Value ($000) $26,373 Avg Close $46.18 Range $41.01 - $53.70

Q1 2024

Shares 643,751 Value ($000) $30,134 Avg Close $39.13 Range $33.67 - $47.58

Q4 2023

Shares 680,370 Value ($000) $24,208 Avg Close $30.67 Range $25.35 - $37.88

Q3 2023

Shares 792,920 Value ($000) $23,581 Avg Close $20.61 Range $15.76 - $31.00

Q2 2023

Shares 475,000 Value ($000) $8,560 Avg Close $19.94 Range $15.50 - $24.58

Q3 2020

Shares 50,000 Value ($000) $784 Avg Close $15.29 Range $13.12 - $18.12

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	130,902	$5,452	$31.97	$25.83 - $47.41
Q2 2025	433,431	$12,465	$30.88	$24.10 - $34.68
Q1 2025	523,431	$17,556	$37.35	$31.65 - $53.55
Q4 2024	516,431	$26,405	$55.95	$49.48 - $62.53
Q3 2024	426,913	$21,815	$51.57	$43.71 - $55.78
Q2 2024	588,818	$26,373	$46.18	$41.01 - $53.70
Q1 2024	643,751	$30,134	$39.13	$33.67 - $47.58
Q4 2023	680,370	$24,208	$30.67	$25.35 - $37.88
Q3 2023	792,920	$23,581	$20.61	$15.76 - $31.00
Q2 2023	475,000	$8,560	$19.94	$15.50 - $24.58
Q3 2020	50,000	$784	$15.29	$13.12 - $18.12